

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 6.23156937 |
| 2 | DNA deamination (GO:0045006) | 5.46319242 |
| 3 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 5.21012816 |
| 4 | pyrimidine nucleotide catabolic process (GO:0006244) | 4.99739169 |
| 5 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.85972241 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 4.79001525 |
| 7 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.66660878 |
| 8 | positive regulation of megakaryocyte differentiation (GO:0045654) | 4.56477582 |
| 9 | heme biosynthetic process (GO:0006783) | 4.53137593 |
| 10 | hemoglobin metabolic process (GO:0020027) | 4.36588812 |
| 11 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.14200133 |
| 12 | thrombin receptor signaling pathway (GO:0070493) | 4.06499821 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.96479214 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.96479214 |
| 15 | deoxyribonucleotide catabolic process (GO:0009264) | 3.95349632 |
| 16 | aerobic respiration (GO:0009060) | 3.92124341 |
| 17 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.91792934 |
| 18 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 3.87438960 |
| 19 | regulation of megakaryocyte differentiation (GO:0045652) | 3.85243054 |
| 20 | oxidative phosphorylation (GO:0006119) | 3.83951515 |
| 21 | heme metabolic process (GO:0042168) | 3.83537546 |
| 22 | short-chain fatty acid metabolic process (GO:0046459) | 3.81259935 |
| 23 | positive regulation of granulocyte differentiation (GO:0030854) | 3.77051600 |
| 24 | oxygen transport (GO:0015671) | 3.76658755 |
| 25 | blood coagulation, intrinsic pathway (GO:0007597) | 3.76251107 |
| 26 | deoxyribose phosphate catabolic process (GO:0046386) | 3.75278766 |
| 27 | potassium ion export (GO:0071435) | 3.61189896 |
| 28 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.56991598 |
| 29 | NADH dehydrogenase complex assembly (GO:0010257) | 3.56991598 |
| 30 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.56991598 |
| 31 | protein complex biogenesis (GO:0070271) | 3.56538408 |
| 32 | tetrapyrrole biosynthetic process (GO:0033014) | 3.54097327 |
| 33 | protein neddylation (GO:0045116) | 3.52080657 |
| 34 | granulocyte differentiation (GO:0030851) | 3.46577987 |
| 35 | gas transport (GO:0015669) | 3.38035043 |
| 36 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.32117564 |
| 37 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.30902788 |
| 38 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.30689675 |
| 39 | porphyrin-containing compound metabolic process (GO:0006778) | 3.30610947 |
| 40 | regulation of skeletal muscle contraction (GO:0014819) | 3.29998738 |
| 41 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.29803829 |
| 42 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.29611680 |
| 43 | mitochondrial calcium ion transport (GO:0006851) | 3.28583961 |
| 44 | actin-myosin filament sliding (GO:0033275) | 3.27228348 |
| 45 | muscle filament sliding (GO:0030049) | 3.27228348 |
| 46 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.25393179 |
| 47 | platelet dense granule organization (GO:0060155) | 3.21242248 |
| 48 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.18923667 |
| 49 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.10205670 |
| 50 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.09614478 |
| 51 | response to thyroid hormone (GO:0097066) | 3.08669269 |
| 52 | glycerol ether metabolic process (GO:0006662) | 3.06799070 |
| 53 | platelet formation (GO:0030220) | 3.06576401 |
| 54 | deoxyribose phosphate metabolic process (GO:0019692) | 3.06198071 |
| 55 | ubiquinone biosynthetic process (GO:0006744) | 3.03863977 |
| 56 | viral transcription (GO:0019083) | 3.02914925 |
| 57 | response to interferon-beta (GO:0035456) | 3.01207000 |
| 58 | regulation of histone H3-K9 methylation (GO:0051570) | 2.98127134 |
| 59 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.97859935 |
| 60 | erythrocyte maturation (GO:0043249) | 2.97047301 |
| 61 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.96060666 |
| 62 | DNA strand elongation (GO:0022616) | 2.95812148 |
| 63 | hydrogen peroxide catabolic process (GO:0042744) | 2.95299500 |
| 64 | ether metabolic process (GO:0018904) | 2.93364637 |
| 65 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.91808885 |
| 66 | cardiolipin metabolic process (GO:0032048) | 2.91321041 |
| 67 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.87858473 |
| 68 | telomere maintenance via recombination (GO:0000722) | 2.87411528 |
| 69 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.86055456 |
| 70 | meiotic chromosome segregation (GO:0045132) | 2.85703250 |
| 71 | endothelium development (GO:0003158) | 2.83969738 |
| 72 | translational termination (GO:0006415) | 2.83584237 |
| 73 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.83003745 |
| 74 | creatine metabolic process (GO:0006600) | 2.82374732 |
| 75 | pigment biosynthetic process (GO:0046148) | 2.81770428 |
| 76 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.78898245 |
| 77 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.78898245 |
| 78 | branched-chain amino acid metabolic process (GO:0009081) | 2.77514550 |
| 79 | branched-chain amino acid catabolic process (GO:0009083) | 2.76796433 |
| 80 | translational elongation (GO:0006414) | 2.76684008 |
| 81 | NADH metabolic process (GO:0006734) | 2.76446378 |
| 82 | respiratory chain complex IV assembly (GO:0008535) | 2.73325010 |
| 83 | positive regulation of B cell differentiation (GO:0045579) | 2.72352291 |
| 84 | cellular respiration (GO:0045333) | 2.71760918 |
| 85 | protein targeting to ER (GO:0045047) | 2.70892954 |
| 86 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.70453417 |
| 87 | L-phenylalanine catabolic process (GO:0006559) | 2.70453417 |
| 88 | cotranslational protein targeting to membrane (GO:0006613) | 2.70014482 |
| 89 | fatty acid beta-oxidation (GO:0006635) | 2.69701694 |
| 90 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.69679801 |
| 91 | deoxyribonucleotide metabolic process (GO:0009262) | 2.69229246 |
| 92 | L-phenylalanine metabolic process (GO:0006558) | 2.68435497 |
| 93 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.68435497 |
| 94 | base-excision repair, AP site formation (GO:0006285) | 2.68029213 |
| 95 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.67879678 |
| 96 | valine metabolic process (GO:0006573) | 2.67477359 |
| 97 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.66911016 |
| 98 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.66886512 |
| 99 | regulation of RIG-I signaling pathway (GO:0039535) | 2.65899681 |
| 100 | proteasome assembly (GO:0043248) | 2.65853396 |
| 101 | endosome to melanosome transport (GO:0035646) | 2.65775051 |
| 102 | endosome to pigment granule transport (GO:0043485) | 2.65775051 |
| 103 | platelet aggregation (GO:0070527) | 2.64726430 |
| 104 | myeloid cell development (GO:0061515) | 2.64685514 |
| 105 | lipoxygenase pathway (GO:0019372) | 2.62641116 |
| 106 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.58889860 |
| 107 | respiratory electron transport chain (GO:0022904) | 2.58434814 |
| 108 | ether lipid metabolic process (GO:0046485) | 2.58331187 |
| 109 | protein localization to endoplasmic reticulum (GO:0070972) | 2.57578125 |
| 110 | definitive hemopoiesis (GO:0060216) | 2.57339126 |
| 111 | daunorubicin metabolic process (GO:0044597) | 2.57223556 |
| 112 | polyketide metabolic process (GO:0030638) | 2.57223556 |
| 113 | doxorubicin metabolic process (GO:0044598) | 2.57223556 |
| 114 | response to methylmercury (GO:0051597) | 2.56990036 |
| 115 | telomere maintenance via telomere lengthening (GO:0010833) | 2.56281628 |
| 116 | mitotic recombination (GO:0006312) | 2.56086594 |
| 117 | fatty acid oxidation (GO:0019395) | 2.55083381 |
| 118 | erythrocyte differentiation (GO:0030218) | 2.54739238 |
| 119 | ubiquinone metabolic process (GO:0006743) | 2.53809353 |
| 120 | purine nucleobase metabolic process (GO:0006144) | 2.53788849 |
| 121 | secretory granule organization (GO:0033363) | 2.53280602 |
| 122 | electron transport chain (GO:0022900) | 2.53225891 |
| 123 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.52866077 |
| 124 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.52866077 |
| 125 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.52323375 |
| 126 | purine-containing compound salvage (GO:0043101) | 2.52136660 |
| 127 | quinone biosynthetic process (GO:1901663) | 2.51614655 |
| 128 | negative regulation of viral genome replication (GO:0045071) | 2.51508634 |
| 129 | IMP biosynthetic process (GO:0006188) | 2.49924560 |
| 130 | regulation of necroptotic process (GO:0060544) | 2.45503711 |
| 131 | necroptotic process (GO:0070266) | 2.45188378 |
| 132 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.43489007 |
| 133 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.42148470 |
| 134 | regulation of erythrocyte differentiation (GO:0045646) | 2.41853004 |
| 135 | translesion synthesis (GO:0019985) | 2.41063931 |
| 136 | cytochrome complex assembly (GO:0017004) | 2.40753974 |
| 137 | iron-sulfur cluster assembly (GO:0016226) | 2.40477192 |
| 138 | metallo-sulfur cluster assembly (GO:0031163) | 2.40477192 |
| 139 | signal peptide processing (GO:0006465) | 2.40248891 |
| 140 | cellular response to interferon-beta (GO:0035458) | 2.39206386 |
| 141 | erythrocyte development (GO:0048821) | 2.38717793 |
| 142 | telomere maintenance (GO:0000723) | 2.38513791 |
| 143 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.38269146 |
| 144 | organic cation transport (GO:0015695) | 2.37712325 |
| 145 | DNA replication initiation (GO:0006270) | 2.36644985 |
| 146 | negative regulation of granulocyte differentiation (GO:0030853) | 2.35748803 |
| 147 | response to interferon-alpha (GO:0035455) | 2.34504561 |
| 148 | tetrapyrrole metabolic process (GO:0033013) | 2.34317714 |
| 149 | telomere organization (GO:0032200) | 2.33731198 |
| 150 | mitochondrial RNA metabolic process (GO:0000959) | 2.32870638 |
| 151 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.32849861 |
| 152 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.32829734 |
| 153 | NIK/NF-kappaB signaling (GO:0038061) | 2.32708650 |
| 154 | lysine catabolic process (GO:0006554) | 2.32603985 |
| 155 | lysine metabolic process (GO:0006553) | 2.32603985 |
| 156 | centriole assembly (GO:0098534) | 2.32338423 |
| 157 | embryonic hemopoiesis (GO:0035162) | 2.31402418 |
| 158 | ribosomal small subunit biogenesis (GO:0042274) | 2.29630623 |
| 159 | neutrophil activation involved in immune response (GO:0002283) | 2.28977033 |
| 160 | IMP metabolic process (GO:0046040) | 2.27585207 |
| 161 | response to type I interferon (GO:0034340) | 2.27474069 |
| 162 | megakaryocyte development (GO:0035855) | 2.26606080 |
| 163 | type I interferon signaling pathway (GO:0060337) | 2.26093357 |
| 164 | cellular response to type I interferon (GO:0071357) | 2.26093357 |
| 165 | DNA unwinding involved in DNA replication (GO:0006268) | 2.24933290 |
| 166 | toxin transport (GO:1901998) | 2.24784200 |
| 167 | T cell apoptotic process (GO:0070231) | 2.24278644 |
| 168 | sperm-egg recognition (GO:0035036) | 2.22568022 |
| 169 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.22381990 |
| 170 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.21231373 |
| 171 | maturation of SSU-rRNA (GO:0030490) | 2.21072250 |
| 172 | response to protozoan (GO:0001562) | 2.20192361 |
| 173 | response to peptidoglycan (GO:0032494) | 2.19636493 |
| 174 | regulation of gamma-delta T cell activation (GO:0046643) | 2.18954439 |
| 175 | defense response to protozoan (GO:0042832) | 2.18872346 |
| 176 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.17610443 |
| 177 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.16838220 |
| 178 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.16172753 |
| 179 | tRNA methylation (GO:0030488) | 2.14207155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 6.89841149 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.55874973 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.29178311 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.25874780 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.14172776 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.74369902 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.71646757 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.64462552 |
| 9 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.54906255 |
| 10 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.54370909 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.46482234 |
| 12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.43816343 |
| 13 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29301925 |
| 14 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26732095 |
| 15 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.14448022 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.04392715 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.03167325 |
| 18 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03003998 |
| 19 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.01800728 |
| 20 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.01616976 |
| 21 | GATA2_19941826_ChIP-Seq_K562_Human | 2.01003059 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.00451670 |
| 23 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.94239769 |
| 24 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.93398985 |
| 25 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.85442846 |
| 26 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.84688878 |
| 27 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.84482018 |
| 28 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.80498412 |
| 29 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.79280289 |
| 30 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.78462092 |
| 31 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.77753700 |
| 32 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77299396 |
| 33 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.76808982 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.74042053 |
| 35 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.73814777 |
| 36 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.70451970 |
| 37 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.70123767 |
| 38 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.70058842 |
| 39 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.69115742 |
| 40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.68112737 |
| 41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.67479704 |
| 42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.67299982 |
| 43 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.67297928 |
| 44 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.66752676 |
| 45 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.65683939 |
| 46 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.64860060 |
| 47 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.62000957 |
| 48 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.60839002 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60506035 |
| 50 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.59244427 |
| 51 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.58378223 |
| 52 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.57173982 |
| 53 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.56116644 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.55601696 |
| 55 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.53381713 |
| 56 | MYC_22102868_ChIP-Seq_BL_Human | 1.52746535 |
| 57 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.51445767 |
| 58 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50780401 |
| 59 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.50557501 |
| 60 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.49015131 |
| 61 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.48710387 |
| 62 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.48375223 |
| 63 | MYB_26560356_Chip-Seq_TH2_Human | 1.46818589 |
| 64 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.46685698 |
| 65 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.45743678 |
| 66 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.45318356 |
| 67 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.44923538 |
| 68 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.44531191 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43849147 |
| 70 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42627267 |
| 71 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.38944052 |
| 72 | MYB_26560356_Chip-Seq_TH1_Human | 1.38635106 |
| 73 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.37091625 |
| 74 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36029216 |
| 75 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.35745606 |
| 76 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.35569337 |
| 77 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.34791119 |
| 78 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.33254243 |
| 79 | MAF_26560356_Chip-Seq_TH1_Human | 1.31630631 |
| 80 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.31117481 |
| 81 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.30903223 |
| 82 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.30821883 |
| 83 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.30672699 |
| 84 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.29951900 |
| 85 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29919724 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28923393 |
| 87 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.27308941 |
| 88 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.26176272 |
| 89 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.24556496 |
| 90 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24512311 |
| 91 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.23795201 |
| 92 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.23390170 |
| 93 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.23075495 |
| 94 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.21107308 |
| 95 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.19556877 |
| 96 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.17995842 |
| 97 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.16046925 |
| 98 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15772431 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.15419074 |
| 100 | * P300_27268052_Chip-Seq_Bcells_Human | 1.13988300 |
| 101 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13608497 |
| 102 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.13289423 |
| 103 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.13259318 |
| 104 | UTX_26944678_Chip-Seq_JUKART_Human | 1.12155018 |
| 105 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.11977498 |
| 106 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.10269617 |
| 107 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.09627302 |
| 108 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.08431661 |
| 109 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05778796 |
| 110 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.05361724 |
| 111 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05076890 |
| 112 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.04980949 |
| 113 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.03902929 |
| 114 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.03508286 |
| 115 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.02520927 |
| 116 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.00217123 |
| 117 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.00122045 |
| 118 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.00119794 |
| 119 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.00069829 |
| 120 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.99419453 |
| 121 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.99339867 |
| 122 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.98257036 |
| 123 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.98095802 |
| 124 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.98081932 |
| 125 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96990117 |
| 126 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96947308 |
| 127 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.96425207 |
| 128 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.95975582 |
| 129 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95445110 |
| 130 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94936733 |
| 131 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93628842 |
| 132 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.93421413 |
| 133 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.92672354 |
| 134 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.92400744 |
| 135 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92188552 |
| 136 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89002022 |
| 137 | SPI1_23127762_ChIP-Seq_K562_Human | 0.87847111 |
| 138 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.86115904 |
| 139 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84583239 |
| 140 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.83525926 |
| 141 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.82791849 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004147_increased_porphyrin_level | 3.39976292 |
| 2 | MP0003656_abnormal_erythrocyte_physiolo | 3.23074841 |
| 3 | MP0002396_abnormal_hematopoietic_system | 3.12366859 |
| 4 | MP0004145_abnormal_muscle_electrophysio | 2.99521822 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.69471895 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 2.67806391 |
| 7 | MP0000685_abnormal_immune_system | 2.59354248 |
| 8 | MP0001545_abnormal_hematopoietic_system | 2.39816395 |
| 9 | MP0005397_hematopoietic_system_phenotyp | 2.39816395 |
| 10 | MP0009785_altered_susceptibility_to | 2.36592002 |
| 11 | MP0003718_maternal_effect | 2.30364250 |
| 12 | MP0005451_abnormal_body_composition | 2.21184003 |
| 13 | MP0005464_abnormal_platelet_physiology | 2.15936142 |
| 14 | MP0004808_abnormal_hematopoietic_stem | 2.13294397 |
| 15 | MP0000490_abnormal_crypts_of | 2.09777477 |
| 16 | MP0008057_abnormal_DNA_replication | 2.07805923 |
| 17 | MP0005410_abnormal_fertilization | 2.05270862 |
| 18 | MP0004036_abnormal_muscle_relaxation | 1.97022110 |
| 19 | MP0003436_decreased_susceptibility_to | 1.95213521 |
| 20 | MP0003195_calcinosis | 1.91251187 |
| 21 | MP0005671_abnormal_response_to | 1.87497842 |
| 22 | MP0002139_abnormal_hepatobiliary_system | 1.85805992 |
| 23 | MP0003724_increased_susceptibility_to | 1.84340636 |
| 24 | MP0005025_abnormal_response_to | 1.83105475 |
| 25 | MP0006036_abnormal_mitochondrial_physio | 1.82129103 |
| 26 | MP0008004_abnormal_stomach_pH | 1.79001822 |
| 27 | MP0002398_abnormal_bone_marrow | 1.76784023 |
| 28 | MP0005174_abnormal_tail_pigmentation | 1.76301722 |
| 29 | MP0001800_abnormal_humoral_immune | 1.73336538 |
| 30 | MP0006054_spinal_hemorrhage | 1.70832297 |
| 31 | MP0008058_abnormal_DNA_repair | 1.70688159 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.68708765 |
| 33 | MP0009764_decreased_sensitivity_to | 1.65883582 |
| 34 | MP0004215_abnormal_myocardial_fiber | 1.65644797 |
| 35 | MP0000372_irregular_coat_pigmentation | 1.63641586 |
| 36 | MP0005360_urolithiasis | 1.63593972 |
| 37 | MP0002419_abnormal_innate_immunity | 1.62708730 |
| 38 | MP0002723_abnormal_immune_serum | 1.60938790 |
| 39 | MP0005075_abnormal_melanosome_morpholog | 1.60267918 |
| 40 | MP0002452_abnormal_antigen_presenting | 1.58927240 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.58871712 |
| 42 | MP0005000_abnormal_immune_tolerance | 1.57828268 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.57292632 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.57029426 |
| 45 | MP0004084_abnormal_cardiac_muscle | 1.56028871 |
| 46 | MP0001790_abnormal_immune_system | 1.54606390 |
| 47 | MP0005387_immune_system_phenotype | 1.54606390 |
| 48 | MP0003763_abnormal_thymus_physiology | 1.52872287 |
| 49 | MP0010155_abnormal_intestine_physiology | 1.52111701 |
| 50 | MP0010094_abnormal_chromosome_stability | 1.51308005 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.50360741 |
| 52 | MP0002722_abnormal_immune_system | 1.50153199 |
| 53 | MP0001853_heart_inflammation | 1.49103174 |
| 54 | MP0001819_abnormal_immune_cell | 1.48110877 |
| 55 | MP0005646_abnormal_pituitary_gland | 1.48049863 |
| 56 | MP0002638_abnormal_pupillary_reflex | 1.44092967 |
| 57 | MP0002429_abnormal_blood_cell | 1.42442447 |
| 58 | MP0003111_abnormal_nucleus_morphology | 1.42346098 |
| 59 | MP0005085_abnormal_gallbladder_physiolo | 1.40192670 |
| 60 | MP0000716_abnormal_immune_system | 1.40180845 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.40155964 |
| 62 | MP0008469_abnormal_protein_level | 1.38739477 |
| 63 | MP0003646_muscle_fatigue | 1.38402877 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 1.37986307 |
| 65 | MP0005365_abnormal_bile_salt | 1.36288291 |
| 66 | MP0003866_abnormal_defecation | 1.34784353 |
| 67 | MP0003186_abnormal_redox_activity | 1.33099861 |
| 68 | MP0001845_abnormal_inflammatory_respons | 1.31392309 |
| 69 | MP0002006_tumorigenesis | 1.30062589 |
| 70 | MP0001873_stomach_inflammation | 1.29896021 |
| 71 | MP0002405_respiratory_system_inflammati | 1.28613240 |
| 72 | MP0005330_cardiomyopathy | 1.25944781 |
| 73 | MP0008789_abnormal_olfactory_epithelium | 1.25493029 |
| 74 | MP0005535_abnormal_body_temperature | 1.24068218 |
| 75 | MP0003252_abnormal_bile_duct | 1.23278896 |
| 76 | MP0003693_abnormal_embryo_hatching | 1.20546580 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 1.18893056 |
| 78 | MP0006035_abnormal_mitochondrial_morpho | 1.17724521 |
| 79 | MP0003077_abnormal_cell_cycle | 1.17144224 |
| 80 | MP0005084_abnormal_gallbladder_morpholo | 1.16965980 |
| 81 | MP0005266_abnormal_metabolism | 1.16026440 |
| 82 | MP0008007_abnormal_cellular_replicative | 1.16007914 |
| 83 | MP0008775_abnormal_heart_ventricle | 1.15765831 |
| 84 | MP0001764_abnormal_homeostasis | 1.13725388 |
| 85 | MP0005666_abnormal_adipose_tissue | 1.13200253 |
| 86 | MP0003191_abnormal_cellular_cholesterol | 1.10163108 |
| 87 | MP0000609_abnormal_liver_physiology | 1.10090643 |
| 88 | MP0003806_abnormal_nucleotide_metabolis | 1.08842153 |
| 89 | MP0002106_abnormal_muscle_physiology | 1.08180785 |
| 90 | MP0002095_abnormal_skin_pigmentation | 1.07641504 |
| 91 | MP0000703_abnormal_thymus_morphology | 1.07473933 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 1.06681943 |
| 93 | MP0000230_abnormal_systemic_arterial | 1.05809479 |
| 94 | MP0002971_abnormal_brown_adipose | 1.04531037 |
| 95 | MP0005083_abnormal_biliary_tract | 1.04294147 |
| 96 | MP0002019_abnormal_tumor_incidence | 1.03946351 |
| 97 | MP0009697_abnormal_copulation | 1.03380850 |
| 98 | MP0009763_increased_sensitivity_to | 1.02110710 |
| 99 | MP0008872_abnormal_physiological_respon | 0.99755720 |
| 100 | MP0003300_gastrointestinal_ulcer | 0.99465538 |
| 101 | MP0008995_early_reproductive_senescence | 0.98914812 |
| 102 | MP0003011_delayed_dark_adaptation | 0.98673354 |
| 103 | MP0002877_abnormal_melanocyte_morpholog | 0.98356156 |
| 104 | MP0010329_abnormal_lipoprotein_level | 0.95999825 |
| 105 | MP0005394_taste/olfaction_phenotype | 0.95593604 |
| 106 | MP0005499_abnormal_olfactory_system | 0.95593604 |
| 107 | MP0002078_abnormal_glucose_homeostasis | 0.93006177 |
| 108 | MP0004130_abnormal_muscle_cell | 0.92904751 |
| 109 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92528955 |
| 110 | MP0003786_premature_aging | 0.90947002 |
| 111 | MP0000747_muscle_weakness | 0.90752603 |
| 112 | MP0009643_abnormal_urine_homeostasis | 0.90299399 |
| 113 | MP0005670_abnormal_white_adipose | 0.90277169 |
| 114 | MP0004142_abnormal_muscle_tone | 0.90069693 |
| 115 | MP0001666_abnormal_nutrient_absorption | 0.90054499 |
| 116 | MP0003698_abnormal_male_reproductive | 0.89073283 |
| 117 | MP0005058_abnormal_lysosome_morphology | 0.88470491 |
| 118 | MP0008875_abnormal_xenobiotic_pharmacok | 0.88202002 |
| 119 | MP0009278_abnormal_bone_marrow | 0.87873563 |
| 120 | MP0002269_muscular_atrophy | 0.87463876 |
| 121 | MP0001533_abnormal_skeleton_physiology | 0.87345872 |
| 122 | MP0001984_abnormal_olfaction | 0.85857867 |
| 123 | MP0000598_abnormal_liver_morphology | 0.85660910 |
| 124 | MP0001661_extended_life_span | 0.84970611 |
| 125 | MP0000751_myopathy | 0.84159402 |
| 126 | MP0002132_abnormal_respiratory_system | 0.83895151 |
| 127 | MP0005369_muscle_phenotype | 0.83485737 |
| 128 | MP0003172_abnormal_lysosome_physiology | 0.83337871 |
| 129 | MP0003638_abnormal_response/metabolism_ | 0.83269820 |
| 130 | MP0005620_abnormal_muscle_contractility | 0.83152329 |
| 131 | MP0004947_skin_inflammation | 0.82655352 |
| 132 | MP0003868_abnormal_feces_composition | 0.82147312 |
| 133 | MP0004085_abnormal_heartbeat | 0.82102990 |
| 134 | MP0000313_abnormal_cell_death | 0.81758147 |
| 135 | MP0000015_abnormal_ear_pigmentation | 0.81428565 |
| 136 | MP0005332_abnormal_amino_acid | 0.80958215 |
| 137 | MP0001929_abnormal_gametogenesis | 0.80164940 |
| 138 | MP0002118_abnormal_lipid_homeostasis | 0.80098524 |
| 139 | MP0006276_abnormal_autonomic_nervous | 0.79698822 |
| 140 | MP0000749_muscle_degeneration | 0.79624707 |
| 141 | MP0000343_altered_response_to | 0.78275064 |
| 142 | MP0009765_abnormal_xenobiotic_induced | 0.75553166 |
| 143 | MP0001986_abnormal_taste_sensitivity | 0.74905449 |
| 144 | MP0005220_abnormal_exocrine_pancreas | 0.74828760 |
| 145 | MP0002102_abnormal_ear_morphology | 0.74640798 |
| 146 | MP0002332_abnormal_exercise_endurance | 0.74504683 |
| 147 | MP0004957_abnormal_blastocyst_morpholog | 0.74447819 |
| 148 | MP0004087_abnormal_muscle_fiber | 0.73996114 |
| 149 | MP0001485_abnormal_pinna_reflex | 0.71972437 |
| 150 | MP0002972_abnormal_cardiac_muscle | 0.69153934 |
| 151 | MP0000358_abnormal_cell_content/ | 0.68244183 |
| 152 | MP0005376_homeostasis/metabolism_phenot | 0.66745943 |
| 153 | MP0008874_decreased_physiological_sensi | 0.64106109 |
| 154 | MP0002822_catalepsy | 0.63658105 |
| 155 | MP0005645_abnormal_hypothalamus_physiol | 0.60371629 |
| 156 | MP0001663_abnormal_digestive_system | 0.59850215 |
| 157 | MP0001529_abnormal_vocalization | 0.59733329 |
| 158 | MP0009642_abnormal_blood_homeostasis | 0.59378718 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 5.97068757 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 4.42088721 |
| 3 | Thrombocytosis (HP:0001894) | 4.25070076 |
| 4 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.11804398 |
| 5 | Exercise-induced myalgia (HP:0003738) | 4.01047986 |
| 6 | Increased mean platelet volume (HP:0011877) | 3.87920751 |
| 7 | Menorrhagia (HP:0000132) | 3.71724396 |
| 8 | Prolonged bleeding time (HP:0003010) | 3.71417951 |
| 9 | Muscle fiber inclusion bodies (HP:0100299) | 3.70530533 |
| 10 | Nemaline bodies (HP:0003798) | 3.66559537 |
| 11 | Severe visual impairment (HP:0001141) | 3.66136934 |
| 12 | Abnormal platelet volume (HP:0011876) | 3.56630716 |
| 13 | Petechiae (HP:0000967) | 3.53370604 |
| 14 | Poikilocytosis (HP:0004447) | 3.51270817 |
| 15 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.49761651 |
| 16 | Acute encephalopathy (HP:0006846) | 3.44611342 |
| 17 | Paralysis (HP:0003470) | 3.42814071 |
| 18 | Reduced antithrombin III activity (HP:0001976) | 3.42147892 |
| 19 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.27402726 |
| 20 | Acute necrotizing encephalopathy (HP:0006965) | 3.22583779 |
| 21 | Myositis (HP:0100614) | 3.14374581 |
| 22 | Cerebral palsy (HP:0100021) | 3.12967970 |
| 23 | Acanthocytosis (HP:0001927) | 3.05259691 |
| 24 | Mitochondrial inheritance (HP:0001427) | 3.00380830 |
| 25 | Myoglobinuria (HP:0002913) | 2.99412789 |
| 26 | Epistaxis (HP:0000421) | 2.96670981 |
| 27 | Hyperbilirubinemia (HP:0002904) | 2.93851556 |
| 28 | IgM deficiency (HP:0002850) | 2.88912980 |
| 29 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.86802824 |
| 30 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.86802824 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.77377971 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.76697744 |
| 33 | Increased intramyocellular lipid droplets (HP:0012240) | 2.72730797 |
| 34 | Progressive macrocephaly (HP:0004481) | 2.71000860 |
| 35 | Impaired platelet aggregation (HP:0003540) | 2.70211919 |
| 36 | Abnormal platelet function (HP:0011869) | 2.70211919 |
| 37 | Nasal polyposis (HP:0100582) | 2.69173899 |
| 38 | Tubulointerstitial nephritis (HP:0001970) | 2.66726991 |
| 39 | Type I transferrin isoform profile (HP:0003642) | 2.66144349 |
| 40 | Hepatic necrosis (HP:0002605) | 2.64421484 |
| 41 | Cholelithiasis (HP:0001081) | 2.63918997 |
| 42 | Recurrent abscess formation (HP:0002722) | 2.63442363 |
| 43 | Nausea (HP:0002018) | 2.62820880 |
| 44 | Abnormal protein glycosylation (HP:0012346) | 2.62324738 |
| 45 | Abnormal glycosylation (HP:0012345) | 2.62324738 |
| 46 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.62324738 |
| 47 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.62324738 |
| 48 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.60388202 |
| 49 | Hyperthyroidism (HP:0000836) | 2.59517749 |
| 50 | Reticulocytopenia (HP:0001896) | 2.58893416 |
| 51 | Increased CSF lactate (HP:0002490) | 2.58864236 |
| 52 | Aplastic anemia (HP:0001915) | 2.56887453 |
| 53 | Renal Fanconi syndrome (HP:0001994) | 2.54286477 |
| 54 | Rimmed vacuoles (HP:0003805) | 2.53155207 |
| 55 | Renal cortical cysts (HP:0000803) | 2.47000140 |
| 56 | Increased serum ferritin (HP:0003281) | 2.46196443 |
| 57 | Exercise-induced muscle cramps (HP:0003710) | 2.45856642 |
| 58 | Recurrent bacterial skin infections (HP:0005406) | 2.43730360 |
| 59 | Abnormality of the nasal mucosa (HP:0000433) | 2.43371052 |
| 60 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.41395684 |
| 61 | Abnormal gallbladder physiology (HP:0012438) | 2.41114015 |
| 62 | Cholecystitis (HP:0001082) | 2.41114015 |
| 63 | Visual hallucinations (HP:0002367) | 2.41079223 |
| 64 | Orchitis (HP:0100796) | 2.39902827 |
| 65 | Abnormality of reticulocytes (HP:0004312) | 2.39714968 |
| 66 | Chronic otitis media (HP:0000389) | 2.38949491 |
| 67 | Type 2 muscle fiber atrophy (HP:0003554) | 2.38398455 |
| 68 | Cerebral edema (HP:0002181) | 2.35994827 |
| 69 | Ragged-red muscle fibers (HP:0003200) | 2.35950299 |
| 70 | Gingival bleeding (HP:0000225) | 2.35670662 |
| 71 | Abnormality of iron homeostasis (HP:0011031) | 2.33818495 |
| 72 | Hepatocellular necrosis (HP:0001404) | 2.31655755 |
| 73 | Abnormality of lateral ventricle (HP:0030047) | 2.30809823 |
| 74 | Abnormality of T cell physiology (HP:0011840) | 2.29056084 |
| 75 | Reticulocytosis (HP:0001923) | 2.28927092 |
| 76 | Hyperammonemia (HP:0001987) | 2.27018227 |
| 77 | Muscle fiber atrophy (HP:0100295) | 2.26893167 |
| 78 | Generalized aminoaciduria (HP:0002909) | 2.24276570 |
| 79 | Exercise intolerance (HP:0003546) | 2.24113416 |
| 80 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.22940743 |
| 81 | Lactic acidosis (HP:0003128) | 2.21106788 |
| 82 | Hyperglycinemia (HP:0002154) | 2.19668251 |
| 83 | Ventricular fibrillation (HP:0001663) | 2.19637660 |
| 84 | Microcytic anemia (HP:0001935) | 2.18548215 |
| 85 | Poikiloderma (HP:0001029) | 2.17664060 |
| 86 | Retrobulbar optic neuritis (HP:0100654) | 2.17159348 |
| 87 | Optic neuritis (HP:0100653) | 2.17159348 |
| 88 | Pendular nystagmus (HP:0012043) | 2.16481841 |
| 89 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.16231406 |
| 90 | Recurrent bronchitis (HP:0002837) | 2.14608620 |
| 91 | Hypoglycemic coma (HP:0001325) | 2.11270600 |
| 92 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.10492442 |
| 93 | Neurodegeneration (HP:0002180) | 2.10255933 |
| 94 | Pallor (HP:0000980) | 2.09807835 |
| 95 | Hypoplasia of the thymus (HP:0000778) | 2.03507883 |
| 96 | Recurrent viral infections (HP:0004429) | 2.03394330 |
| 97 | 3-Methylglutaconic aciduria (HP:0003535) | 2.01261264 |
| 98 | Abnormality of renal resorption (HP:0011038) | 2.00755559 |
| 99 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.98855950 |
| 100 | Amaurosis fugax (HP:0100576) | 1.96928660 |
| 101 | Muscle stiffness (HP:0003552) | 1.96622772 |
| 102 | Metabolic acidosis (HP:0001942) | 1.93827299 |
| 103 | Polycythemia (HP:0001901) | 1.93395848 |
| 104 | Sudden death (HP:0001699) | 1.93268370 |
| 105 | Abnormality of the gallbladder (HP:0005264) | 1.92355252 |
| 106 | Abnormal pupillary function (HP:0007686) | 1.92148852 |
| 107 | Calf muscle hypertrophy (HP:0008981) | 1.91199024 |
| 108 | Abnormality of the intrinsic pathway (HP:0010989) | 1.90686685 |
| 109 | Inflammation of the large intestine (HP:0002037) | 1.89427398 |
| 110 | Respiratory failure (HP:0002878) | 1.89209343 |
| 111 | Recurrent skin infections (HP:0001581) | 1.88641081 |
| 112 | Microvesicular hepatic steatosis (HP:0001414) | 1.88467139 |
| 113 | Pancytopenia (HP:0001876) | 1.88026448 |
| 114 | Gastrointestinal inflammation (HP:0004386) | 1.87995739 |
| 115 | Myelodysplasia (HP:0002863) | 1.85609321 |
| 116 | Abnormal spermatogenesis (HP:0008669) | 1.85469656 |
| 117 | Abnormality of T cells (HP:0002843) | 1.84656393 |
| 118 | Increased muscle lipid content (HP:0009058) | 1.84495078 |
| 119 | Acute myeloid leukemia (HP:0004808) | 1.83782680 |
| 120 | Neutropenia (HP:0001875) | 1.82918385 |
| 121 | Meningitis (HP:0001287) | 1.82174974 |
| 122 | Hypochromic anemia (HP:0001931) | 1.80671964 |
| 123 | Hyperglycinuria (HP:0003108) | 1.80505474 |
| 124 | Polyneuropathy (HP:0001271) | 1.80270436 |
| 125 | EMG: neuropathic changes (HP:0003445) | 1.80032247 |
| 126 | Arterial thrombosis (HP:0004420) | 1.79858061 |
| 127 | Muscle fiber splitting (HP:0003555) | 1.79650868 |
| 128 | Lethargy (HP:0001254) | 1.79635836 |
| 129 | Abnormality of B cell number (HP:0010975) | 1.79571118 |
| 130 | B lymphocytopenia (HP:0010976) | 1.79571118 |
| 131 | Basal ganglia calcification (HP:0002135) | 1.79542435 |
| 132 | Hypertriglyceridemia (HP:0002155) | 1.78065108 |
| 133 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.77928515 |
| 134 | Periodontitis (HP:0000704) | 1.77706978 |
| 135 | Rhabdomyolysis (HP:0003201) | 1.77544395 |
| 136 | Macrocytic anemia (HP:0001972) | 1.76177552 |
| 137 | Cutaneous photosensitivity (HP:0000992) | 1.75814912 |
| 138 | Areflexia of lower limbs (HP:0002522) | 1.75416002 |
| 139 | Encephalitis (HP:0002383) | 1.75109275 |
| 140 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.75031157 |
| 141 | Dicarboxylic aciduria (HP:0003215) | 1.75031157 |
| 142 | Abnormality of the prostate (HP:0008775) | 1.73869160 |
| 143 | Exertional dyspnea (HP:0002875) | 1.73864694 |
| 144 | Hyperlipoproteinemia (HP:0010980) | 1.73531907 |
| 145 | 11 pairs of ribs (HP:0000878) | 1.73392934 |
| 146 | Abnormality of urine glucose concentration (HP:0011016) | 1.73237373 |
| 147 | Glycosuria (HP:0003076) | 1.73237373 |
| 148 | Autoimmune thrombocytopenia (HP:0001973) | 1.73209812 |
| 149 | Abnormal gallbladder morphology (HP:0012437) | 1.73186379 |
| 150 | Distal arthrogryposis (HP:0005684) | 1.72761984 |
| 151 | Fatigue (HP:0012378) | 1.72343036 |
| 152 | Tinnitus (HP:0000360) | 1.71989815 |
| 153 | Eczematoid dermatitis (HP:0000976) | 1.71752619 |
| 154 | Nonimmune hydrops fetalis (HP:0001790) | 1.71614962 |
| 155 | Thrombophlebitis (HP:0004418) | 1.71574113 |
| 156 | Progressive muscle weakness (HP:0003323) | 1.70948234 |
| 157 | Purpura (HP:0000979) | 1.70933351 |
| 158 | Hepatosplenomegaly (HP:0001433) | 1.70698324 |
| 159 | EMG: myopathic abnormalities (HP:0003458) | 1.70288280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 3.87600010 |
| 2 | VRK2 | 3.59141841 |
| 3 | NUAK1 | 2.68104764 |
| 4 | SRPK1 | 2.67508320 |
| 5 | IRAK3 | 2.64840134 |
| 6 | MAP4K2 | 2.62631491 |
| 7 | NME2 | 2.52425436 |
| 8 | TEC | 2.37261468 |
| 9 | PHKG1 | 2.29981283 |
| 10 | PHKG2 | 2.29981283 |
| 11 | FLT3 | 2.28133491 |
| 12 | BLK | 2.22850407 |
| 13 | TBK1 | 2.13956921 |
| 14 | MAP4K1 | 2.07992277 |
| 15 | KIT | 1.95716767 |
| 16 | MUSK | 1.95246371 |
| 17 | MAP3K14 | 1.92994021 |
| 18 | MST4 | 1.91528326 |
| 19 | TYK2 | 1.88958034 |
| 20 | TAOK3 | 1.82075888 |
| 21 | BCKDK | 1.82074435 |
| 22 | STK16 | 1.76234308 |
| 23 | MAP2K3 | 1.72737487 |
| 24 | NEK1 | 1.72341557 |
| 25 | IRAK4 | 1.71531214 |
| 26 | EIF2AK1 | 1.68472942 |
| 27 | BTK | 1.68223144 |
| 28 | JAK3 | 1.67592545 |
| 29 | ZAP70 | 1.63901454 |
| 30 | EEF2K | 1.63849359 |
| 31 | PKN2 | 1.59931073 |
| 32 | PIM2 | 1.58973396 |
| 33 | IKBKE | 1.57037436 |
| 34 | ARAF | 1.50728365 |
| 35 | INSRR | 1.48624827 |
| 36 | ACVR1B | 1.47044909 |
| 37 | CDC7 | 1.43942354 |
| 38 | ZAK | 1.38741461 |
| 39 | WEE1 | 1.35323546 |
| 40 | IKBKB | 1.34850912 |
| 41 | ERN1 | 1.33200384 |
| 42 | PDK3 | 1.32592862 |
| 43 | PDK4 | 1.32592862 |
| 44 | BRSK2 | 1.31574277 |
| 45 | RAF1 | 1.31028463 |
| 46 | TNK2 | 1.29667597 |
| 47 | PLK4 | 1.23499261 |
| 48 | NEK2 | 1.22647498 |
| 49 | TGFBR1 | 1.20367482 |
| 50 | SYK | 1.16592946 |
| 51 | RPS6KA4 | 1.16454159 |
| 52 | MAPK12 | 1.13079676 |
| 53 | TXK | 1.12816482 |
| 54 | EIF2AK2 | 1.12286606 |
| 55 | BMX | 1.11201407 |
| 56 | DYRK3 | 1.10800601 |
| 57 | BUB1 | 1.10494003 |
| 58 | MAP2K4 | 1.09422855 |
| 59 | PIM1 | 1.08950668 |
| 60 | VRK1 | 1.08865977 |
| 61 | CSF1R | 1.05746868 |
| 62 | EIF2AK3 | 1.04893648 |
| 63 | TGFBR2 | 1.03569648 |
| 64 | MAP3K1 | 1.01876418 |
| 65 | ABL2 | 1.00799208 |
| 66 | PNCK | 0.99012078 |
| 67 | ATR | 0.98405045 |
| 68 | DAPK3 | 0.96763845 |
| 69 | JAK1 | 0.94715505 |
| 70 | NEK9 | 0.92008134 |
| 71 | STK10 | 0.91798711 |
| 72 | STK4 | 0.89909998 |
| 73 | PKN1 | 0.89445741 |
| 74 | CDK7 | 0.89214490 |
| 75 | STK24 | 0.89148307 |
| 76 | MAP3K6 | 0.86671367 |
| 77 | FES | 0.86514071 |
| 78 | RIPK4 | 0.85912601 |
| 79 | MAPK13 | 0.84424138 |
| 80 | TRPM7 | 0.84205360 |
| 81 | MAP2K6 | 0.81809431 |
| 82 | LYN | 0.81186890 |
| 83 | KDR | 0.81076598 |
| 84 | MATK | 0.80526555 |
| 85 | JAK2 | 0.78706337 |
| 86 | IRAK1 | 0.77865419 |
| 87 | DAPK2 | 0.75609045 |
| 88 | PASK | 0.74743367 |
| 89 | PRKG2 | 0.73514567 |
| 90 | MAPKAPK3 | 0.72896796 |
| 91 | LRRK2 | 0.72834591 |
| 92 | CDK8 | 0.72032747 |
| 93 | MAP2K7 | 0.71970523 |
| 94 | MAPK11 | 0.71901974 |
| 95 | MAP3K13 | 0.71887103 |
| 96 | CHUK | 0.70410583 |
| 97 | BRSK1 | 0.69092088 |
| 98 | CDK4 | 0.69081313 |
| 99 | TAF1 | 0.67400659 |
| 100 | MAP3K5 | 0.66832410 |
| 101 | RPS6KA5 | 0.66367466 |
| 102 | CAMKK2 | 0.66201559 |
| 103 | TRIB3 | 0.64904174 |
| 104 | TIE1 | 0.64130520 |
| 105 | MAP3K7 | 0.61966762 |
| 106 | TAOK2 | 0.60938812 |
| 107 | PIK3CG | 0.60631402 |
| 108 | TLK1 | 0.59825561 |
| 109 | LCK | 0.59225265 |
| 110 | PRKAA2 | 0.58875028 |
| 111 | TESK1 | 0.57023526 |
| 112 | FRK | 0.56484704 |
| 113 | CCNB1 | 0.56260869 |
| 114 | FGFR4 | 0.56148159 |
| 115 | TESK2 | 0.55612544 |
| 116 | CDK19 | 0.54861171 |
| 117 | RPS6KA6 | 0.52805530 |
| 118 | DYRK2 | 0.52051032 |
| 119 | AURKB | 0.51571696 |
| 120 | AURKA | 0.51454559 |
| 121 | MAP3K11 | 0.51175675 |
| 122 | SCYL2 | 0.50940834 |
| 123 | ITK | 0.50310463 |
| 124 | PRKCQ | 0.50245669 |
| 125 | MAP3K10 | 0.48339660 |
| 126 | PTK2B | 0.48103971 |
| 127 | WNK3 | 0.47886805 |
| 128 | TTK | 0.47527607 |
| 129 | MAP3K3 | 0.46789907 |
| 130 | HIPK2 | 0.46519651 |
| 131 | DYRK1B | 0.45432604 |
| 132 | RPS6KB2 | 0.44877118 |
| 133 | NME1 | 0.43153972 |
| 134 | CDK6 | 0.42763061 |
| 135 | PRKG1 | 0.41522596 |
| 136 | BRAF | 0.41154214 |
| 137 | TAOK1 | 0.40011370 |
| 138 | PRKACA | 0.38774559 |
| 139 | DAPK1 | 0.38583700 |
| 140 | MAPK3 | 0.37926962 |
| 141 | TTN | 0.37718860 |
| 142 | PBK | 0.37117631 |
| 143 | MAPK4 | 0.36912664 |
| 144 | RPS6KC1 | 0.36618940 |
| 145 | RPS6KL1 | 0.36618940 |
| 146 | CSNK2A2 | 0.36163314 |
| 147 | CAMK2G | 0.35320993 |
| 148 | HCK | 0.35208841 |
| 149 | PRKACG | 0.34491357 |
| 150 | PAK1 | 0.34379491 |
| 151 | MAP3K8 | 0.34146857 |
| 152 | ATM | 0.34018390 |
| 153 | MARK3 | 0.33867077 |
| 154 | MINK1 | 0.32536113 |
| 155 | CAMK1 | 0.32040778 |
| 156 | ILK | 0.30331977 |
| 157 | MAPKAPK5 | 0.30187646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.73850673 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.49197836 |
| 3 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 3.23493467 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 2.94298003 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.83773210 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.69622118 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.53022517 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.23706466 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 2.23027278 |
| 10 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.14725107 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 1.98914381 |
| 12 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.90686495 |
| 13 | Platelet activation_Homo sapiens_hsa04611 | 1.88503655 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.87544488 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.85125256 |
| 16 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.69021136 |
| 17 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.64216244 |
| 18 | Alzheimers disease_Homo sapiens_hsa05010 | 1.57958896 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.57531907 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.56782305 |
| 21 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.55625894 |
| 22 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.54351642 |
| 23 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.48775851 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.46371642 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.43891596 |
| 26 | Sulfur relay system_Homo sapiens_hsa04122 | 1.43193206 |
| 27 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.42576050 |
| 28 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.41986218 |
| 29 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.40720982 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.40254090 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.38502650 |
| 32 | Measles_Homo sapiens_hsa05162 | 1.38265511 |
| 33 | Leishmaniasis_Homo sapiens_hsa05140 | 1.35540632 |
| 34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.35286756 |
| 35 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.33900361 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.33122116 |
| 37 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.29515875 |
| 38 | * Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.27754417 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.27705474 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.26928111 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.26479164 |
| 42 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.22747360 |
| 43 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.20754501 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.20313589 |
| 45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.19019891 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.18887064 |
| 47 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.18461767 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.18397628 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 1.18338555 |
| 50 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.18200634 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.17228795 |
| 52 | Protein export_Homo sapiens_hsa03060 | 1.12180464 |
| 53 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.12149377 |
| 54 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.09590009 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.08545421 |
| 56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.07773634 |
| 57 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.07375204 |
| 58 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.07067042 |
| 59 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.04101644 |
| 60 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04045013 |
| 61 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04014855 |
| 62 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.02852808 |
| 63 | RNA degradation_Homo sapiens_hsa03018 | 1.01803231 |
| 64 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.01451508 |
| 65 | Purine metabolism_Homo sapiens_hsa00230 | 1.00028392 |
| 66 | Cell cycle_Homo sapiens_hsa04110 | 0.98048483 |
| 67 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.97028880 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.96290747 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.93233511 |
| 70 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.91968996 |
| 71 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.89514224 |
| 72 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.88670966 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.88294198 |
| 74 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.87716433 |
| 75 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86267276 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 0.85977262 |
| 77 | Circadian rhythm_Homo sapiens_hsa04710 | 0.84873749 |
| 78 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.84129839 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.84047894 |
| 80 | Proteasome_Homo sapiens_hsa03050 | 0.83095913 |
| 81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81882853 |
| 82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.81486368 |
| 83 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.81340301 |
| 84 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.81221537 |
| 85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.79493705 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.79472881 |
| 87 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.78557800 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76858523 |
| 89 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.75751522 |
| 90 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.75036613 |
| 91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73207698 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.73190847 |
| 93 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.72475522 |
| 94 | Olfactory transduction_Homo sapiens_hsa04740 | 0.72221808 |
| 95 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.71706832 |
| 96 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.70776085 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.70562374 |
| 98 | Influenza A_Homo sapiens_hsa05164 | 0.70334434 |
| 99 | Spliceosome_Homo sapiens_hsa03040 | 0.69352878 |
| 100 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.68949871 |
| 101 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66936859 |
| 102 | RNA polymerase_Homo sapiens_hsa03020 | 0.66482682 |
| 103 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65927963 |
| 104 | Basal transcription factors_Homo sapiens_hsa03022 | 0.65498209 |
| 105 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.64480868 |
| 106 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.63952863 |
| 107 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.63293646 |
| 108 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.63248829 |
| 109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.62435403 |
| 110 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.59908702 |
| 111 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58708862 |
| 112 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.57999852 |
| 113 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.57696347 |
| 114 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57693760 |
| 115 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.57574070 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56416548 |
| 117 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.55978781 |
| 118 | RNA transport_Homo sapiens_hsa03013 | 0.55133555 |
| 119 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.54370497 |
| 120 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53935285 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53021336 |
| 122 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.52850199 |
| 123 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.51788177 |
| 124 | Pertussis_Homo sapiens_hsa05133 | 0.51613529 |
| 125 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51498206 |
| 126 | Lysine degradation_Homo sapiens_hsa00310 | 0.51323521 |
| 127 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.51312956 |
| 128 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51030313 |
| 129 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50253045 |
| 130 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49964405 |
| 131 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49520693 |
| 132 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47036182 |
| 133 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46585472 |
| 134 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.46578808 |
| 135 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46569245 |
| 136 | Phototransduction_Homo sapiens_hsa04744 | 0.42620315 |
| 137 | Alcoholism_Homo sapiens_hsa05034 | 0.39884317 |
| 138 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.38385372 |
| 139 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.30729719 |
| 140 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.29673676 |
| 141 | Malaria_Homo sapiens_hsa05144 | 0.29412217 |
| 142 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29151412 |
| 143 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.27194986 |
| 144 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.27125896 |
| 145 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25585233 |
| 146 | Retinol metabolism_Homo sapiens_hsa00830 | 0.23930298 |

